The Scientist : An innovative approach to vaccination against tumors [7/9/2001]

Supplements

Survey Series

The Scientist Daily

Science headlines delivered daily.
Register today.

For Advertisers

by Tudor Toma

RESEARCH ROUND-UP

An innovative approach to vaccination against tumors

Fusion of chaperone protein calreticulin to HPV-16 E7 gene can generate an impressive antitumor effect.

Email: Tudor Toma - t.toma@ic.ac.uk
News from The Scientist 2001, 2(1):20010907-02

Published

7 September 2001

Antigen-specific cancer immunotherapy and anti-angiogenesis represent two attractive mechanisms that could be of use in the treatment of cancer. In September 1 Journal of Clinical Investigation, Wen-Fang Cheng and colleagues from Johns Hopkins University School of Medicine show an innovative vaccination approach that combines both mechanisms and suggest this is likely generate a potent antitumor effect.

Password

> Forgot Password?
> FAQ
> Subscribe

Subscribing to The Scientist is easy and inexpensive.

And you can choose from many options. Try us out with an online day pass starting at only $4.95. Or, get it all with unlimited online access to The Scientist Archive and door-to-door delivery of our monthly print magazine.


	The Scientist also offers site licenses to institutions and organizations. When your librarian adds The Scientist to the library's collection, you can get unlimited online access through your place of work or study. Recommend The Scientist today